Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Efavirenz and CYP2B6 polymorphism: implications for drug toxicity and resistance.

× No keyword cloud information.

13 in total

1. Long-term efficacy and safety of efavirenz dose reduction to 200 mg once daily in a Caucasian patient with HIV.

Authors: Salvador Cabrera Figueroa; Alicia Iglesias Gómez; Almudena Sánchez Martín; María de la Paz Valverde Merino; Alfonso Domínguez-Gil Hurlé; Miguel Cordero Sánchez
Journal: Clin Drug Investig Date: 2010 Impact factor: 2.859

Review 2. Efavirenz Metabolism: Influence of Polymorphic CYP2B6 Variants and Stereochemistry.

Authors: Pan-Fen Wang; Alicia Neiner; Evan D Kharasch
Journal: Drug Metab Dispos Date: 2019-07-19 Impact factor: 3.922

Review 3. PharmGKB summary: Efavirenz pathway, pharmacokinetics.

Authors: Ellen M McDonagh; Johnathan L Lau; Maria L Alvarellos; Russ B Altman; Teri E Klein
Journal: Pharmacogenet Genomics Date: 2015-07 Impact factor: 2.089

4. Rapid clinical induction of hepatic cytochrome P4502B6 activity by ritonavir.

Authors: Evan D Kharasch; Darain Mitchell; Rebecka Coles; Roberto Blanco
Journal: Antimicrob Agents Chemother Date: 2008-02-19 Impact factor: 5.191

5. Low level of efavirenz in HIV-1-infected Thai adults is associated with the CYP2B6 polymorphism.

Authors: C Sukasem; W Manosuthi; N Koomdee; S Santon; T Jantararoungtong; S Prommas; M Chamnanphol; A Puangpetch; S Sungkanuparph
Journal: Infection Date: 2013-11-30 Impact factor: 3.553

Review 6. CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme.

Authors: Hongbing Wang; Leslie M Tompkins
Journal: Curr Drug Metab Date: 2008-09 Impact factor: 3.731

7. Stereoselective metabolism of bupropion by cytochrome P4502B6 (CYP2B6) and human liver microsomes.

Authors: Rebecka Coles; Evan D Kharasch
Journal: Pharm Res Date: 2008-06 Impact factor: 4.200

8. Induction of cytochrome P450 2B6 activity by the herbal medicine baicalin as measured by bupropion hydroxylation.

Authors: Lan Fan; Jin-Chao Wang; Feng Jiang; Zhi-Rong Tan; Yao Chen; Qing Li; Wei Zhang; Guo Wang; He-Ping Lei; Dong-Li Hu; Dan Wang; Hong-Hao Zhou
Journal: Eur J Clin Pharmacol Date: 2008-12-09 Impact factor: 2.953

9. Use of enantiomeric bupropion and hydroxybupropion to assess CYP2B6 activity in glomerular kidney diseases.

Authors: Melanie S Joy; Reginald F Frye; Kristi Stubbert; Kim R Brouwer; Ronald J Falk; Evan D Kharasch
Journal: J Clin Pharmacol Date: 2010-01-26 Impact factor: 3.126

10. Case report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variation.

Authors: Francoise Pinillos; Collet Dandara; Marelize Swart; Renate Strehlau; Louise Kuhn; Faeezah Patel; Ashraf Coovadia; Elaine Abrams
Journal: BMC Infect Dis Date: 2016-02-02 Impact factor: 3.090